tiprankstipranks
Trending News
More News >
Corvus Pharmaceuticals Inc (CRVS)
NASDAQ:CRVS
US Market

Corvus Pharmaceuticals (CRVS) Balance Sheet

Compare
675 Followers

Corvus Pharmaceuticals Balance Sheet

Corvus Pharmaceuticals's total assets for Q4 2025 were $71.12M, a decrease of -11.62% from the previous quarter. CRVS total liabilities were $9.91M for the fiscal quarter, a 13.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 71.12M$ 68.91M$ 45.55M$ 68.24M$ 109.45M
Total Liabilities
$ 9.91M$ 36.34M$ 6.87M$ 12.13M$ 12.29M
Total Equity Gross Minority
$ 61.20M$ 32.57M$ 38.68M$ 56.12M$ 97.16M
Other Metrics
Currency in USD

Corvus Pharmaceuticals Debt to Assets